Cargando…
Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
BACKGROUND: Androgen excess is a defining feature of polycystic ovary syndrome (PCOS), which affects 10% of women and represents a lifelong metabolic disorder, with increased risk of type 2 diabetes, hypertension, and cardiovascular events. Previous studies have suggested an increased risk of nonalc...
Autores principales: | Kumarendran, Balachandran, O’Reilly, Michael W., Manolopoulos, Konstantinos N., Toulis, Konstantinos A., Gokhale, Krishna M., Sitch, Alice J., Wijeyaratne, Chandrika N., Coomarasamy, Arri, Arlt, Wiebke, Nirantharakumar, Krishnarajah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873722/ https://www.ncbi.nlm.nih.gov/pubmed/29590099 http://dx.doi.org/10.1371/journal.pmed.1002542 |
Ejemplares similares
-
Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study
por: Kumarendran, Balachandran, et al.
Publicado: (2019) -
Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study
por: Kumarendran, Balachandran, et al.
Publicado: (2021) -
Serum testosterone, sex hormone‐binding globulin and sex‐specific risk of incident type 2 diabetes in a retrospective primary care cohort
por: O’Reilly, Michael W., et al.
Publicado: (2018) -
Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020) -
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
por: Subramanian, Anuradhaa, et al.
Publicado: (2021)